Pharmanutra Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	126.63	115.5	100.2	82.72	68.11	56.45
Other Revenue	0.52	0.65	0.5	0.34	0.03	0.32
Revenue	127.15	116.15	100.71	83.06	68.14	56.77
Revenue Growth (YoY)	12.73%	15.33%	21.24%	21.89%	20.04%	5.78%
Cost of Revenue	61.95	56.91	52.09	41.14	35.99	30.25
Gross Profit	65.2	59.24	48.62	41.92	32.15	26.52
Selling, General & Admin	31.79	26.67	22.55	17.19	12.12	9.95
Other Operating Expenses	2.18	1.81	0.43	0.34	0.34	1.11
Operating Expenses	37.02	31.88	25.6	18.84	13.86	12.35
Operating Income	28.18	27.36	23.02	23.07	18.3	14.17
Interest Expense	-0.76	-1.06	-0.8	-0.06	-0.02	-0.03
Interest & Investment Income	0.72	0.68	0.32	0.13	0.15	0.09
Currency Exchange Gain (Loss)	-0.01	-0.04	0.08	-0.03	-	0
Other Non Operating Income (Expenses)	0.78	0.77	1.17	0.34	0.4	0.66
EBT Excluding Unusual Items	28.91	27.71	23.79	23.45	18.83	14.88
Gain (Loss) on Sale of Assets	-0.25	-0.27	-0.03	-0.03	-0.02	-0.07
Legal Settlements	-0.27	-0.27	-0.5	-	-	-
Other Unusual Items	-	-	-	-	-	-1.51
Pretax Income	28.39	27.16	23.26	23.42	18.81	13.3
Income Tax Expense	11.07	10.61	10.43	8.37	5.04	-0.77
Earnings From Continuing Operations	17.32	16.55	12.83	15.05	13.77	14.07
Net Income to Company	-	16.55	12.83	15.05	13.77	14.07
Minority Interest in Earnings	0.13	0.06	-	-	-	-
Net Income	17.45	16.61	12.83	15.05	13.77	14.07
Preferred Dividends & Other Adjustments	-	-	-	-	-	0
Net Income to Common	17.45	16.61	12.83	15.05	13.77	14.07
Net Income Growth	7.23%	29.43%	-14.73%	9.27%	-2.14%	66.45%
Shares Outstanding (Basic)	10	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10	10
Shares Change (YoY)	-0.58%	-0.61%	-0.05%	-0.09%	-	-
EPS (Basic)	1.82	1.73	1.33	1.56	1.42	1.45
EPS (Diluted)	1.82	1.73	1.33	1.56	1.42	1.45
EPS Growth	7.86%	30.22%	-14.69%	9.37%	-2.13%	66.44%
Free Cash Flow	10.42	16.25	-1.16	-8.69	15.43	10.12
Free Cash Flow Per Share	1.09	1.69	-0.12	-0.90	1.59	1.04
Dividend Per Share	1.000	1.000	0.850	0.800	0.710	0.670
Dividend Growth	17.65%	17.65%	6.25%	12.68%	5.97%	45.65%
Gross Margin	51.28%	51.00%	48.28%	50.47%	47.18%	46.71%
Operating Margin	22.16%	23.56%	22.86%	27.78%	26.85%	24.95%
Profit Margin	13.72%	14.30%	12.74%	18.12%	20.21%	24.79%
Free Cash Flow Margin	8.20%	13.99%	-1.15%	-10.46%	22.64%	17.82%
EBITDA	31.2	30.24	25.44	24.22	19.3	15.1
EBITDA Margin	24.54%	26.04%	25.26%	29.16%	28.33%	26.60%
D&A For EBITDA	3.02	2.88	2.42	1.15	1.01	0.93
EBIT	28.18	27.36	23.02	23.07	18.3	14.17
EBIT Margin	22.16%	23.56%	22.86%	27.78%	26.85%	24.95%
Effective Tax Rate	38.98%	39.06%	44.83%	35.74%	26.78%	-
Revenue as Reported	41.98	116.91	101.96	83.39	68.84	58.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.